Recruiting NA Copd

New treatment option for Copd

Official title The Effect of Education and Reminder Messages on the Fatigue Level of Individuals With COPD

ClinicalTrials.gov ID: NCT06286072

What this study is testing

What it's testing
COPD is an important respiratory system disease that progresses with damage to the airways.Increased mucus secretion and thickening in the airways causes obstruction.This obstruction causes symptoms such as shortness of breath, cough, phlegm and wheezing.The most obvious problem that the emerging symptoms will cause for the patient is fatigue.Coping with fatigue is an important problem in COPD. The main questions it aims to answer are: 1.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 85

You may be able to join if

  • Diagnosed with COPD for the last 1 year
  • Hospitalized for at least 3 days,
  • Voluntary patients

You likely can't join if

  • Under 18 years old
  • Over 85 years old
  • Those with chronic fatigue syndrome
  • Those with severe heart failure
  • Those who had surgery in the last 6 months

The study team makes the final eligibility decision.

Where it's taking place

  • Kırşehir, Center, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Kırşehir, Center, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.